Hewes L. Becker - Insider Transactions
Insider Type
individual
Companies
1
Average
505,649
Total Txns
11
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 8 | -8 | 0.00 | 4,671,496.89 | -4,671,496.89 |
| 2025 | 0 | 3 | -3 | 0.00 | 890,638.80 | -890,638.80 |
| Total: | 0 | 11 | 10 | 0.00 | 5,562,135.69 | -5,562,135.69 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
88.80 USD |
4,863 Sold |
431,834 USD |
05/03/2025 | 05/03/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
87.42 USD |
2,691 Sold |
235,247 USD |
05/03/2025 | 06/03/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
87.98 USD |
2,541 Sold |
223,557 USD |
05/03/2025 | 06/03/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
104.91 USD |
2,424 Sold |
254,302 USD |
04/06/2024 | 04/06/2024 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
104.83 USD |
6,342 Sold |
664,832 USD |
31/05/2024 | 31/05/2024 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
106.43 USD |
2,971 Sold |
316,204 USD |
31/05/2024 | 03/06/2024 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
107.86 USD |
3,671 Sold |
395,954 USD |
31/05/2024 | 31/05/2024 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
106.43 USD |
1,951 Sold |
207,645 USD |
31/05/2024 | 03/06/2024 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
106.50 USD |
3,191 Sold |
339,842 USD |
31/05/2024 | 31/05/2024 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
105.81 USD |
20,904 Sold |
2,211,852 USD |
31/05/2024 | 31/05/2024 |